Evidence map›Paper›PMID 36408258›Full record

ArticleFrontiers in pharmacology2022

Mechanisms of sympathoexcitation

Anna Mosshammer, Lifang Zou, Stefan Boehm, Klaus Schicker

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Mitochondrial Glutamine Metabolism Drives Epileptogenesis in Primary Hippocampal Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Anna MosshammerDivision of Neurophysiology and Neuropharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Lifang ZouDivision of Neurophysiology and Neuropharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Stefan BoehmDivision of Neurophysiology and Neuropharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Klaus SchickerDivision of Neurophysiology and Neuropharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF DOC 33
6 · The paper itself

Abstract

Many drugs used in cardiovascular therapy, such as angiotensin receptor antagonists and beta-blockers, may exert at least some of their actions through effects on the sympathetic nervous system, and this also holds true for e.g., P2Y

Indexed as

Ca2+-activated Cl-channelexcitabilitynoradrenaline releaseP2Y6 receptorsympathetic neuron

Identifiers

PMID36408258
PMCPMC9669757
OpenAlexW4308416206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.